Buy Acorda Therapeutics Stock | ACOR Stock Price & Latest News | Public
ACOR

Acorda Therapeutics

    Small Market Cap

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Acorda Therapeutics (ACOR) stock trends here

    About ACOR

    Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include AMPYRA (dalfampridine), INBRIJA (levodopa inhalation powder), BTT1023 (timolumab), SYN120, rHIgM22, ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.32
    -0.69
    -1.7
    -2.72
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$2.72

    Actual EPS
    Q1 2021

    Stats

    Market Cap$75,58M
    Volume101,17k
    Price-to-Earnings Ratio1.43
    Dividend Rate
    Dividend Yield
    1 Year High$15.30
    1 Year Low$2.53
    Open$7.00
    High$8.39
    Low$7.00

    Buy any stock with any amount of money.

    Download the App
    Download the app